Correlation Between Arcus Biosciences and FibroBiologics, Common
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and FibroBiologics, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and FibroBiologics, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and FibroBiologics, Common Stock, you can compare the effects of market volatilities on Arcus Biosciences and FibroBiologics, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of FibroBiologics, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and FibroBiologics, Common.
Diversification Opportunities for Arcus Biosciences and FibroBiologics, Common
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Arcus and FibroBiologics, is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and FibroBiologics, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroBiologics, Common and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with FibroBiologics, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroBiologics, Common has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and FibroBiologics, Common go up and down completely randomly.
Pair Corralation between Arcus Biosciences and FibroBiologics, Common
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.3 times more return on investment than FibroBiologics, Common. However, Arcus Biosciences is 3.28 times less risky than FibroBiologics, Common. It trades about 0.03 of its potential returns per unit of risk. FibroBiologics, Common Stock is currently generating about -0.03 per unit of risk. If you would invest 1,415 in Arcus Biosciences on September 23, 2024 and sell it today you would earn a total of 135.00 from holding Arcus Biosciences or generate 9.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 84.07% |
| Values | Daily Returns |
Arcus Biosciences vs. FibroBiologics, Common Stock
Performance |
| Timeline |
| Arcus Biosciences |
| FibroBiologics, Common |
Arcus Biosciences and FibroBiologics, Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and FibroBiologics, Common
The main advantage of trading using opposite Arcus Biosciences and FibroBiologics, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, FibroBiologics, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroBiologics, Common will offset losses from the drop in FibroBiologics, Common's long position.| Arcus Biosciences vs. Fate Therapeutics | Arcus Biosciences vs. Sana Biotechnology | Arcus Biosciences vs. Caribou Biosciences | Arcus Biosciences vs. Heron Therapeuti |
| FibroBiologics, Common vs. Fate Therapeutics | FibroBiologics, Common vs. Sana Biotechnology | FibroBiologics, Common vs. Caribou Biosciences | FibroBiologics, Common vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |